Diversified Healthcare Trust

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: US25525P1075
USD
4.78
0.02 (0.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

453.88 k

Shareholding (Mar 2025)

FII

5.14%

Held by 82 FIIs

DII

74.01%

Held by 41 DIIs

Promoter

0.20%

How big is Diversified Healthcare Trust?

22-Jun-2025

As of Jun 18, Diversified Healthcare Trust has a market capitalization of 870.92 million and reported net sales of 1,511.51 million with a net profit of -292.99 million over the latest four quarters.

Market Cap: As of Jun 18, Diversified Healthcare Trust has a market capitalization of 870.92 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Diversified Healthcare Trust reported net sales of 1,511.51 million and a net profit of -292.99 million.<BR><BR>Balance Sheet Snapshot: As of Dec'24, the company reported shareholder's funds of 1,958.84 million and total assets of 5,137.01 million.

Read More

What does Diversified Healthcare Trust do?

22-Jun-2025

Diversified Healthcare Trust is a healthcare REIT focused on healthcare and life sciences, with a market cap of approximately $870.92 million. As of March 2025, it reported net sales of $387 million and a net loss of $9 million, with a dividend yield of 110.13%.

Overview: <BR>Diversified Healthcare Trust is a healthcare real estate investment trust (REIT) focused on healthcare and life sciences, operating within the Realty industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 387 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -9 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 870.92 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 110.13% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: -8.93% <BR>Price to Book: 0.45<BR><BR>Contact Details: <BR>Address: C/O The Rmr Group, Two Newton Pl., 255 Wash. St., Ste. 300 NEWTON MA : 02458 <BR>Tel: 1 617 7968350 <BR>Fax: 1 617 7968349 <BR>Website: https://www.dhcreit.com

Read More

Should I buy, sell or hold Diversified Healthcare Trust?

22-Jun-2025

Who are in the management team of Diversified Healthcare Trust?

22-Jun-2025

As of March 2022, the management team of Diversified Healthcare Trust includes Ms. Lisa Jones (Lead Independent Trustee), Daniel LePage, Mr. Jeffrey Somers, Ms. Jennifer Clark (Managing Trustee), and Mr. John Harrington, all of whom oversee the company's operations and strategy.

As of March 2022, the management team of Diversified Healthcare Trust includes the following individuals:<BR><BR>- Ms. Lisa Jones, Lead Independent Trustee<BR>- Daniel LePage, Independent Trustee<BR>- Mr. Jeffrey Somers, Independent Trustee<BR>- Ms. Jennifer Clark, Managing Trustee<BR>- Mr. John Harrington, Independent Trustee<BR><BR>These members play key roles in overseeing the operations and strategic direction of the company.

Read More

Is Diversified Healthcare Trust overvalued or undervalued?

20-Sep-2025

As of March 1, 2023, Diversified Healthcare Trust's valuation has shifted from attractive to risky due to overvaluation and poor performance metrics, including a Price to Book Value of 0.42 and an EV to EBITDA of 2.14, despite a year-to-date stock return of 95.22% that outperformed the S&P 500.

As of 1 March 2023, the valuation grade for Diversified Healthcare Trust moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, particularly given its significant negative metrics. Key ratios include a Price to Book Value of 0.42, an EV to EBITDA of 2.14, and an EV to Sales of 0.34, all suggesting that the company is not performing well relative to its valuation.<BR><BR>In comparison to its peers, Diversified Healthcare Trust has a P/E ratio of NA due to being loss-making, while one peer shows an EV to EBITDA of 3.7352, indicating a more favorable valuation. Additionally, the company's recent stock performance has been mixed; it has outperformed the S&P 500 with a year-to-date return of 95.22% compared to the index's 12.22%, but it has also seen a decline of 0.88% over the past week while the S&P 500 gained 1.05%.

Read More

Is Diversified Healthcare Trust technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Diversified Healthcare Trust shows a mildly bullish trend with mixed signals from indicators, outperforming the S&P 500 recently but lagging over the past year.

As of 3 October 2025, the technical trend for Diversified Healthcare Trust has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands also reflect a mildly bullish stance. However, the KST is mildly bearish on both weekly and monthly time frames, indicating some underlying weakness. The daily moving averages are bullish, but the Dow Theory shows no trend in both weekly and monthly perspectives. <BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 1.89% and 4.85% compared to the benchmark's 1.09% and 4.15%, respectively. However, over the longer term, the stock's 1-year return of 10.77% lags behind the S&P 500's 17.82%. Overall, the current technical stance is mildly bullish, but with caution due to mixed signals from various indicators.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate of -19.99%

 
2

Flat results in Jun 25

3

Risky -

4

Reducing Promoter Confidence

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 1,036 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

69.69%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-7.73%

stock-summary
Price to Book

0.56

Revenue and Profits:
Net Sales:
383 Million
(Quarterly Results - Jun 2025)
Net Profit:
-92 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
27.81%
0%
27.81%
6 Months
48.45%
0%
48.45%
1 Year
83.14%
0%
83.14%
2 Years
80.38%
0%
80.38%
3 Years
380.45%
0%
380.45%
4 Years
79.03%
0%
79.03%
5 Years
4.82%
0%
4.82%

Diversified Healthcare Trust for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.22%
EBIT Growth (5y)
-19.99%
EBIT to Interest (avg)
0.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
80.52%
ROCE (avg)
12.96%
ROE (avg)
3.33%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.42
EV to EBIT
-11.23
EV to EBITDA
2.14
EV to Capital Employed
0.31
EV to Sales
0.34
PEG Ratio
NA
Dividend Yield
117.62%
ROCE (Latest)
-2.76%
ROE (Latest)
-8.93%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 41 Schemes (20.62%)

Foreign Institutions

Held by 82 Foreign Institutions (5.14%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -1.09% vs 1.92% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -917.78% vs 89.70% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "382.70",
          "val2": "386.90",
          "chgp": "-1.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "58.90",
          "val2": "63.50",
          "chgp": "-7.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "50.90",
          "val2": "57.80",
          "chgp": "-11.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-31.10",
          "val2": "-60.00",
          "chgp": "48.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-91.60",
          "val2": "-9.00",
          "chgp": "-917.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-19.30%",
          "val2": "-12.40%",
          "chgp": "-0.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.03% vs 9.87% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -26.12% vs -1,758.23% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,495.40",
          "val2": "1,410.30",
          "chgp": "6.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "229.90",
          "val2": "207.30",
          "chgp": "10.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "235.20",
          "val2": "191.80",
          "chgp": "22.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-71.10",
          "val2": "-19.30",
          "chgp": "-268.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-370.30",
          "val2": "-293.60",
          "chgp": "-26.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-36.80%",
          "val2": "-54.40%",
          "chgp": "1.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
382.70
386.90
-1.09%
Operating Profit (PBDIT) excl Other Income
58.90
63.50
-7.24%
Interest
50.90
57.80
-11.94%
Exceptional Items
-31.10
-60.00
48.17%
Consolidate Net Profit
-91.60
-9.00
-917.78%
Operating Profit Margin (Excl OI)
-19.30%
-12.40%
-0.69%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -1.09% vs 1.92% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -917.78% vs 89.70% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,495.40
1,410.30
6.03%
Operating Profit (PBDIT) excl Other Income
229.90
207.30
10.90%
Interest
235.20
191.80
22.63%
Exceptional Items
-71.10
-19.30
-268.39%
Consolidate Net Profit
-370.30
-293.60
-26.12%
Operating Profit Margin (Excl OI)
-36.80%
-54.40%
1.76%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 6.03% vs 9.87% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -26.12% vs -1,758.23% in Dec 2023

stock-summaryCompany CV
About Diversified Healthcare Trust stock-summary
stock-summary
Diversified Healthcare Trust
Realty
Diversified Healthcare Trust, formerly Senior Housing Properties Trust, is a healthcare real estate investment trust (REIT). The Company is focused on healthcare and life sciences located throughout the United States. Its segments include triple net senior living communities that provide short term and long term residential care and other services for residents; managed senior living communities that provide short term and long term residential care and other services for residents; properties leased to medical providers, medical related businesses, clinics and biotech laboratory tenants, and all other, including certain properties that offer wellness, fitness and spa services to members. Properties in triple net senior living communities segment include leased independent living communities, assisted living communities and skilled nursing facilities. Properties in managed senior living communities segment include managed independent living communities and assisted living communities.
Company Coordinates stock-summary
Company Details
C/O The Rmr Group, Two Newton Pl., 255 Wash. St., Ste. 300 NEWTON MA : 02458
stock-summary
Tel: 1 617 7968350
stock-summary
Registrar Details